Background. Biologic aggressiveness of head and neck carcinoma is reflected in its capability to metastasize to regional lymph nodes and its propensity to recur after treatment. Methods. The authors report on 244 patients treated at the Department of Otolaryngology-Head and Neck Surgery of the Free
Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer
โ Scribed by Robert P. Takes; Robert J. Baatenburg de Jong; Karien Wijffels; Ed Schuuring; Sergey V. Litvinov; Jo Hermans; J. Han J. M. van Krieken
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 81 KB
- Volume
- 194
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. The aim of this study was to investigate the value of p53 and cyclin D1 gene expression in predicting the risk of occult lymph node metastases in patients with head and neck squamous cell carcinoma (HNSCC). Methods. The expression of cyclin D1 and p53 was evaluated by means of immunohis
In head and neck squamous cell carcinomas (HNSCC), metastasis to cervical lymph nodes is a major determinant of patient outcome. To detect metastases, we used the MET oncogene as marker, which encodes the receptor for hepatocyte growth factor/scatter factor, mediating epithelial cell motility and in
Flow cytometric DNA content measurements have demonstrated extensive DNA ploidy heterogeneity in primary breast carcinomas. However, little is known at the molecular level about the clonal relationship between these tumor cell subpopulations, or about the molecular genetic changes associated with an
## We have previously reported that immune anti-tumor effector cells, both cytotoxic T lymphocytes (CTLs ) and IL-2-activated natural killer (A-NK) cells, are effective at eliminating human head-and-neck cancer (HNC) targets in vitro and in vivo in xenograft models. In this study, these 2 types of